Mosaic Filler Trial for Midface Volume Loss
Part of Skin clinical trials.
This trial tests a new cheek filler called Mosaic for people with moderate to severe cheek volume loss. It helps doctors see if Mosaic is safe and effective for filling out the midface area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have moderate to severe volume loss in both cheeks, as judged by a doctor.
- You cannot have had any type of permanent fillers, facial plastic surgery, or fat injections to your cheeks or lower face ever.
- You must not be allergic to the ingredients in the study filler, including lidocaine, bovine collagen, or beef products.
- You cannot be taking blood thinners or prescription steroids, and you must stop certain over-the-counter supplements before the study.
- You must not have had any facial filler, Botox, or skin lasers in the last 6 to 24 months (depending on the type).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable gel (NOA VOLUME) for restoring fullness in the cheeks, comparing it to an already-approved gel (JUVÉDERM VOLUMA XC). It's for adults with moderate to severe cheek hollowing who want a safe, effective option.
This trial tests a new hyaluronic acid filler called Alcarisa to restore volume in the mid-face (cheek area). It may be a good option if you are looking for a non-surgical way to treat moderate to significant cheek volume loss.
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
This study tests a new injectable filler made of hyaluronic acid (a natural substance that adds volume) to improve the look of lips, smile lines, or cheeks. If you qualify, you'll receive the treatment and be monitored for safety and results.
This trial tests a new way to inject a high-molecular-weight hyaluronic acid filler into the face to improve wrinkles. It is designed for Asian adults and looks at whether the treatment is safe and effective.
This trial tests a new injectable collagen product called MEC REGENERATE® to see if it is safe and works well for improving the appearance of facial skin. It may be an option if you are looking for a non-surgical aesthetic treatment.
Hear when a new Midface Volume Deficit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.